AstraZeneca holds talks with Bristol Myers Squibb on $400bn merger
Tie-up would be one of the biggest-ever pharmaceutical deals and create the world’s fourth-largest drugmakerBusiness live – latest updatesBritain’s biggest drugmaker, AstraZeneca, is understood to be in discussions to take over its US rival Bristol Myers Squibb in a deal that would create a near-$400bn (£300bn) pharmaceutical group.AstraZeneca, run by Pascal Soriot, its longtime chief executive, is the second-bigges…
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
